| Mark William Niemer, MD | |
|
1500 Associates Dr, Dubuque, IA 52002-2201 | |
| (563) 584-4460 | |
| (563) 584-4395 |
| Full Name | Mark William Niemer |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 39 Years |
| Location | 1500 Associates Dr, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275585259 | NPI | - | NPPES |
| 0083279 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 28785 (Iowa) | Primary |
| 207RR0500X | Internal Medicine - Rheumatology | 37106 (Wisconsin) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Clinic Pc | 3870491228 | 192 |
News Archive
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
A novel, four-week parenting rotation designed for pediatric residents has dramatically increased the amount of time resident parents can spend at home with their babies, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
Severely injured patients who are routinely given IV fluids by paramedics before transport to the nearest trauma center are significantly more likely to die than similarly injured patients who don't get the time-consuming IV treatment before hospitalization, new Johns Hopkins-led research suggests.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 7 days ago
| Entity Name | Medical Associates Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457300790 PECOS PAC ID: 3870491228 Enrollment ID: O20031223000311 |
News Archive
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
A novel, four-week parenting rotation designed for pediatric residents has dramatically increased the amount of time resident parents can spend at home with their babies, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
Severely injured patients who are routinely given IV fluids by paramedics before transport to the nearest trauma center are significantly more likely to die than similarly injured patients who don't get the time-consuming IV treatment before hospitalization, new Johns Hopkins-led research suggests.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark William Niemer, MD 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4100 | Mark William Niemer, MD 1500 Associates Dr, Dubuque, IA 52002-2201 Ph: (563) 584-4460 |
News Archive
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
A novel, four-week parenting rotation designed for pediatric residents has dramatically increased the amount of time resident parents can spend at home with their babies, according to a study by researchers at the University of Colorado Anschutz Medical Campus.
Severely injured patients who are routinely given IV fluids by paramedics before transport to the nearest trauma center are significantly more likely to die than similarly injured patients who don't get the time-consuming IV treatment before hospitalization, new Johns Hopkins-led research suggests.
Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.
› Verified 7 days ago
Ryan Elsey, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St Ste 100, Dubuque, IA 52001 Phone: 563-557-9111 Fax: 563-589-4046 | |
Cynthia J. Konz, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St, Ste 100, Dubuque, IA 52001 Phone: 563-557-9111 Fax: 563-589-4046 | |
Kristin Elizabeth Nelson, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1515 Delhi St, Ste 100, Dubuque, IA 52001 Phone: 563-557-9111 Fax: 563-589-4046 | |
Darryl K. Mozena, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi Street, Suite 100, Dubuque, IA 52001 Phone: 563-557-9111 Fax: 563-589-4046 | |
Christine Marie Holm, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 150 Mercy Dr., Dubuque, IA 52001 Phone: 563-584-3480 Fax: 563-584-3481 | |
Brian Leo Loc, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3425 Fax: 563-584-3497 | |
Thomas Anthony Sinsky, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1000 Langworthy St, Dubuque, IA 52001 Phone: 563-584-3430 Fax: 563-584-3394 |